Muscle Spasm Treatments

Muscle Spasm Treatments
MUSCLE SPASM TREATMENTS
Generic Brand Strength Form Usual Adult Dose
Alpha2-ADRENERGIC AGONIST
tizanidine HCl Zanaflex ℞ 4mg scored tabs Usually 4mg, may increase by 2−4mg as needed every 6−8hrs to a max of 3 doses in 24hrs; max 12mg/dose and 36mg/day. Renal impairment (CrCl <25mL/min): Reduce dose. May sprinkle contents of capsules on applesauce (may affect absorption). Tabs and caps not bioequivalent under fed conditions.
2mg, 4mg, 6mg caps
ANTICHOLINERGIC MUSCLE RELAXANT (CENTRAL)
orphenadrine citrate — ℞ 100mg sust-rel tabs 100mg twice daily in AM and PM
℞ 60mg/2mL inj1 60mg IM or IV every 12hrs
BENZODIAZEPINE
diazepam — CIV 5mg/5mL soln 2−10mg 3−4 times daily. Elderly, debilitated: Initially 2−2.5mg 1−2 times daily; increase gradually.
5mg/mL inj4 Initially 5−10mg slow IV (5mg/min) or IM. May repeat after 3−4hrs. Tetanus: May need larger dose. Do not use small vein.
Diazepam Intensol CIV 5mg/mL concen– trated soln2 2−10mg 3−4 times daily Elderly, debilitated: Initially 2−2.5mg 1−2 times daily; increase gradually. Mix with liquid or semi-solid food.
Valium CIV 2mg, 5mg, 10mg scored tabs 2−10mg 3−4 times daily Elderly, debilitated: Initially 2−2.5mg 1−2 times daily; increase gradually.
MUSCLE RELAXANT (CENTRAL)
baclofen — ℞ 5mg, 10mg+, 20mg+ tabs (+scored) 5mg 3 times daily; increase in increments of 5mg 3 times daily every 3 days if needed; max 80mg daily
Gablofen ℞ 50mcg/mL, 500mcg/  mL, 1000mcg/  mL, 2000mcg/  mL intra– thecal inj Give test dose 1st by intrathecal inj via spinal catheter or lumbar puncture (use 50mcg/mL syringe). Dose titration: see full labeling. Maintenance: titrate individually; maintain some degree of muscle tone. Spinal cord origin: usually 300–800mcg/day. Cerebral origin: usually 90–703mcg/day.
Lioresal ℞ 50mcg/mL, 500mcg/  mL, 2000mcg/  mL
Lyvispah ℞ 5mg, 10mg, 20mg oral granules ≥12yrs: Initially 5mg 3 times daily for 3 days. May increase by increments of 5mg 3 times daily every 3 days, as needed; up to max 80mg/day. Can be dissolved in the mouth, swallowed, or mixed with up to 15mL of liquid or soft foods.
carisoprodol Soma CIV 350mg tabs ≥16yrs: 250−350mg 3 times daily and at bedtime; max 2−3wks <16yrs: Not established.
Soma 250 CIV 250mg tabs
chlorzox– azone — ℞ 375mg, 500mg+, 750mg+ tabs (+scored) 250–500mg 3–4 times daily. Painful musculoskeletal conditions: initially 500mg 3–4 times daily. May increase to 750mg 3–4 times daily if inadequate response. May reduce dose based on improvement.
cyclobenza– prine HCl — ℞ 5mg, 10mg, 7.5mg tabs ≥15yrs: Initially 5mg 3 times daily; may increase to 10mg 3 times daily; max 2−3wks. Elderly or hepatic impairment: Initially 5mg, then titrate up. <15yrs: Not established.
Amrix ℞ 15mg, 30mg ext-rel caps 15mg once daily; may increase to 30mg once daily; max 2−3wks. Take at same time each day. Elderly or hepatic impairment: Not recommended.
metaxalone Skelaxin ℞ 800mg scored tabs 800mg 3−4 times daily.
methocar– bamol — ℞ 500mg tabs ≥16yrs: Initially 1.5g 4 times daily for 2−3 days; if severe, may give up to 8g/day Maintenance: 1g 4 times daily <16yrs: Not established.
℞ 750mg tabs ≥16yrs: Initially 1.5g 4 times daily for 2−3 days; if severe, may give up to 8g/day. Maintenance: 750mg every 4hrs or 1.5g 3 times daily. <16yrs: Not established.
MUSCLE RELAXANT (LOCAL)
dantrolene sodium Dantrium ℞ 25mg, 50mg, 100mg caps 25mg once daily for 7 days, then 25mg 3 times daily for 7 days, then 50mg 3 times daily for 7 days, then 100mg 3 times daily; max 100mg 4 times daily
MUSCLE RELAXANT (CENTRAL) + SALICYLATE
carisoprodol — ℞ 200mg tabs 1−2 tabs 4 times daily
aspirin 325mg
MUSCLE RELAXANT (CENTRAL) + SALICYLATE + OPIOID
carisoprodol — CIII 200mg tabs1 1−2 tabs 4 times daily
aspirin 325mg
codeine phosphate 16mg
NEUROMUSCULAR BLOCKERS
abobotuli– numtoxin A Dysport ℞ 300 U/vial, 500 U/vial IM inj3 Spasticity: usual range: 500–1000 Units (upper limb) or 1000–1500 Units (lower limb) divided among selected muscles per treatment session; max 1mL/site. Total max 1500 Units for upper and lower limb combined. May repeat treatment after effect of the previous inj diminishes, but no sooner than 12wks.
incobotuli– numtoxin A Xeomin ℞ 50 U/vial, 100 U/vial, 200 U/vial IM inj3 See full labeling. Upper limb spasticity (not previously treated): initially give dose at the low end of dosing range and titrate as needed. Max cumulative dose: 400 Units in a treatment session. May repeat treatments no sooner than every 12wks.
onabotuli– numtoxin A Botox ℞ 50 U/vial, 100 U/vial, 200 U/vial IM inj3 Upper limb spasticity: usual range: 75–400 Units divided among selected muscles per treatment session; max 50 Units/site. Lower limb spasticity: 300–400 Units divided among 5 muscles; max 50 Units/site. May repeat treatment after effect of the previous inj diminishes, but no sooner than 12wks.
NOTES

1contains sulfites; 2contains alcohol 19%; 3contains human albumin; 4contains propylene glycol 40%, ethyl and benzyl alcohol Not an inclusive list of medications and/or doses. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling.

(Rev. 10/2022)